A Phase 2b, Prospective, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate Efficacy and Safety of Saroglitazar Magnesium in Subjects with Nonalcoholic Steatohepatitis and Fibrosis
Details
Age
Adult
Locations
University of Colorado Hospital
Principal Investigator
Amanda Wieland
Study ID
Protocol Number: 21-3466
More information available at ClinicalTrials.gov: NCT05011305
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers